• bild01

Panikverkäufe bei Cannabis-Aktien
Daniel Schaad - CannabisReport
Link bei facebook teilen :) Link bei twitter teilen :) Link bei google+ teilen :) Link bei XING teilen :) Link bei LinkedIn teilen :)
Canopy Growth und Aurora Cannabis liegen inzwischen 40% unter ihren Hochs vom Januar
Seit November 2017 haben sich viele Marihuana-Aktien im Kurs ver-3-facht oder sind sogar noch stärker gestiegen. Der starke Rücksetzer in den letzten Handelstagen ist ein Zeichen, dass die Überbewertung im Sektor nun abgebaut wird.

Wie es aussieht wurden wohl einige auf dem falschen Fuß erwischt, denn der jüngste Hype dürfte einige neue Kleinanleger angezogen haben, die mit solch einer Volatilität nicht zurecht kommen. Hier haben dann wohl manche ohne Rücksicht auf Verluste die Reissleine gezogen, was einen richtigen Abwärtsstrudel zur Folge hatte.

Alleine heute verloren eine Canopy Growth im Tief 16%, und fiel auf ein neues 6-Wochentief. Aurora gab um 17% nach und Aphria um 14%.

Nachfolgend ein Artikel von "The Globe and Mail" aus Kanada, der genau diese Thematik beschreibt.

© The Globe and Mail, Jen Skerritt, Bloomberg News

Marijuana "panic selling" spurs Canadian pot stocks meltdown

Investors’ collective high over Canada’s burgeoning marijuana industry has evaporated, to be replaced by a comedown.

Marijuana stocks tumbled Friday amid a wave of "panic-selling" and concern that companies that had seen ballooning share prices recently are now overvalued. The BI Canada Cannabis Index plunged as much as 19 per cent, its biggest intraday drop on record, while the nation’s largest producers including Canopy Growth Corp. and Aurora Cannabis Inc. tumbled more than 40 per cent from their January highs.

"There’s a lot of investors that got in in the last month and many of them are looking at significant losses," PI Financial analyst Jason Zandberg said by telephone. "It now looks like it’s a pile-on. There’s a bit of panic selling."

Shares of Canopy tumbled as much as 16 percent in Toronto to the lowest intraday price in six weeks, while Aurora dropped 17 per cent and Aphria Inc. fell 14 per cent.

The plunge comes after some market leaders more than doubled in value since November amid optimism that Canada will legalize pot this year. A wave of consolidation followed, as companies jockey for market share and enough supply to fill provincial retail shelves. Last month, Aurora Cannabis agreed to acquire CanniMed Therapeutics Inc. in a $1.23-billion deal that’s the largest merger ever in the red-hot industry.

Boosted Production

On Friday, the government’s statistics agency released new data that shows Canadian marijuana costs $6.85 a gram. Earlier estimates suggest weed prices have been falling in recent years as illegal producers boosted output in recent years, potentially cutting into the revenue for publicly traded companies that hope to tap into the new market.

Concern that companies are overvalued has helped spark the decline, Zandberg said. While some of the periphery cannabis stocks will probably not survive in the long term, there is enough demand in Canada to transfer over to a legalized market and the industry leaders will thrive, he said.

"People are panicking because they are losing their money," Chris Damas, editor of the BCMI Cannabis Report, said in an email. "Stocks are in bear market territory."

Friday morning’s selling is probably the peak and stocks will likely stabilize from here, Damas said in a note. Still, the Canadian cannabis shares have been overbought and have probably seen their highs for the year, he said.